
STAT Plus: IBM halting sales of Watson AI tool for drug discovery amid sluggish growth
DAVID RAMOS/GETTY IMAGES
The decision to shut down sales of Watson for Drug Discovery marks another setback in the company’s effort to apply AI to various areas of health care.


No hay comentarios:
Publicar un comentario